A phase II, double blind, randomised, dose ranging, safety and efficacy trial of rapid intravenous infusion of zoledronate versus Aredia in breast cancer patients with osteolytic metastases
Phase of Trial: Phase II
Latest Information Update: 08 Apr 2015
At a glance
- Drugs Zoledronic acid (Primary) ; Pamidronic acid
- Indications Advanced breast cancer; Cancer metastases
- Focus Therapeutic Use
- 26 Nov 2005 New trial record.